U.S. FDA Approves KEYTRUDA in Combination with WELIREG for Adjuvant Treatment of Renal Cell Carcinoma
The U.S. FDA has approved KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab with berahyaluro...
South Korea's Rznomics Announces Interim Clinical Data for RZ-001 in Treating rGBM
Rznomics' RNA editing-based anticancer gene therapy, RZ-001 (Taspitimagene advec), has demonstrated ...
Ascendis Reports 182-Week Data for YORVIPATH in Hypoparathyroidism
Danish biopharmaceutical company Ascendis Pharma A/S (Nasdaq: ASND) announced 182-week data from the...
Colombia Passes Bill to Authorize Local Production of Cancer Treatment Radiopharmaceuticals
Colombia's Congress has passed a new bill authorizing the domestic production of radiopharmaceutical...
Netherlands completes world's first in vivo CRISPR Phase III trial, reducing attacks by 87%
The research team has successfully completed the world's first Phase III trial of an in vivo CRISPR ...
US HeroMD Launches 4-MAX Formula, Starting at $3 Per Dose
US-based telemedicine platform HeroMD has launched a compounded prescription sublingual formula, 4-M...
US-based Parabilis Medicines Sets Drug Developer Fundraising Record with $770 Million IPO
Parabilis Medicines (Nasdaq: PBLS) became the largest IPO in drug developer history last week throug...
Japan's NovAccel Plans to Build Factory by 2028 for Mass Production of Actinium-225, Aiming for Global Top Three
Japanese startup NovAccel has announced plans to establish its own factory in eastern Japan around f...
China's Ascentage Pharma Announces 17 Clinical Updates at EHA2026
Ascentage Pharma Group (NASDAQ: AAPG; HKEX: 6855) announced 17 clinical updates on its core assets, ...
Johnson & Johnson's TALVEY Combination Therapy Reduces Risk of Myeloma Progression or Death by 72%
Data from the MonumenTAL-3 clinical trial show that Tal-DP and Tal-D regimens significantly prolonge...
MIT Proposes 3D-Printed Microscopic Three-Layer Droplet Nozzle Solution
Researchers at the Massachusetts Institute of Technology (MIT) have proposed a low-cost 3D printing ...
Monash University: Copper compound reduces toxic proteins by 42% and improves memory
Researchers at Monash University in Australia have discovered in laboratory experiments that a drug ...
US Study Shows Semaglutide Reduces Fracture Risk by 15% in Type 2 Diabetes Patients
A study set to be presented at ENDO 2026, the annual meeting of the Endocrine Society in Chicago, Il...
China's MZ3 Case Packing and Palletizing Machine Integrates Multiple Processes in Vaccine Packaging Line
The MZ3 case packing and palletizing machine can integrate multiple processes in the post-packaging ...
Argentina and Chile Sign Nuclear Technology Cooperation Agreement
Chile and Argentina have signed a new nuclear technology cooperation agreement, marking the first su...
China Unicom Undertakes Construction of National AI Application Pilot Base in Healthcare, Releases Hundred-Million-Yuan Support Plan for High-Quality Datasets
On June 9, the National Artificial Intelligence Application Pilot Base (Healthcare)·Beijing Interim ...
WHO Expands Ebola Surveillance in Central Africa; US Adds $20 Million in Support
The World Health Organization (WHO) is expanding surveillance and response operations for the ongoin...
Chinese Scientists Propose "Pulsatile Activation" Concept and Develop New Drug for Chronic Liver Disease
The team led by Xu Huaqiang and Li Jia from the Shanghai Institute of Materia Medica, Chinese Academ...
Multiple Japanese Institutions Discover New κ-Form Polymorph of Indomethacin
A joint research project conducted by Rigaku Corporation, Shionogi & Co., Ltd., JEOL Ltd., and M...
SK Bioscience of South Korea Licenses Rotavirus Vaccine Technology from US CDC
SK bioscience has initiated process development for an injectable rotavirus vaccine candidate. The c...
Mexico Attracts 21 Billion Pesos in Investment to Strengthen Domestic Pharmaceutical Production
Mexico has recently bolstered domestic pharmaceutical production through industrial policies and pub...
China's Pharmaron Plans 5 Billion Yuan Expansion for Pharmaceutical Intermediates and CDMO Capacity
Pharmaron announced plans to invest a total of 5 billion yuan to build pharmaceutical intermediates ...
Spain's New Health Assessment Regulations Gain Support from Sanofi and Others
Spain's new Royal Decree on Health Technology Assessment, passed in May 2026, is seen as a strategic...
Waters Launches Column Platform to Support GLP-1/LNP Development
Waters Corporation announced at the 55th International Symposium on High-Performance Liquid Phase Se...
Chime Biologics Launches GMP-2 Facility in Wuhan, Plans AI-Driven Super Factory
Chime Biologics announced the official launch of its GMP-2 production facility in Wuhan, China. The ...
Brazil's CADE Reviews EMS's $600 Million Acquisition of Sanofi's Generic Drug Business
Brazil's Administrative Council for Economic Defense (Cade) has initiated a review process for the a...
Sanofi Launches AI Field Concierge Based on Snowflake Cortex AI
Snowflake announced on the 9th that global pharmaceutical company Sanofi has launched a new AI agent...
UK's GSK in Talks to Acquire US Cancer Drug Maker Nuvalent for Over $9 Billion
On June 9, British pharmaceutical company GlaxoSmithKline (GSK) is in talks to acquire Nuvalent, a U...
Brazil's Ávita Care seeks approval for semaglutide weight-loss pen within June
Ávita Care is accelerating the submission of final supplementary materials to Brazil's National Heal...
Perioperative Apalutamide Reduces Risk of Distant Metastasis or Death by 20% in High-Risk Prostate Cancer
A new Phase 3 study in patients with high-risk localized or locally advanced prostate cancer (PCa) h...